Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Bisphosphonates Market Expected to Be in 2029?

The market size for bisphosphonates has seen significant growth in the past few years. It is expected to expand from $5.39 billion in 2024 to $5.7 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.8%. The growth observed in the historic period could be tied to a surge in multiple myeloma incidences, a rise in glucocorticoid-induced osteoporosis cases, an increase in sedentary lifestyles, and more availability of generic bisphosphonates. There has also been a notable increase in its usage for treating metastatic bone disease.

In the forthcoming years, the bisphosphonates market is poised for robust expansion, with forecasts predicting a rise to $7.07 billion in 2029 at a compound annual growth rate of 5.5%. This projected growth during the forecast period pins down to several factors such as amplified investments in bone health studies, escalating demand for cost-efficient osteoporosis treatments, an intensified emphasis on geriatric healthcare, proliferated adoption of bisphosphonates in blossoming markets, and heightened awareness driven by digital health promotional endeavors. Key trends expected to shape this market in the forecast period encompass breakthroughs in drug delivery systems, enhanced formulations that bolster bioavailability, the advent of combination therapies, novel patient adherence technologies, and emerging personalized treatment strategies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24483&type=smp

What Are The Contributors To Demand In The Bisphosphonates Market?

The expected rise in cases of osteoporosis is a key element driving the growth of the bisphosphonates market. Osteoporosis is a health issue where bones become brittle and more likely to fracture. This condition is becoming more prevalent, majorly due to the globally ageing population, as bone density naturally decreases with age, and is often exacerbated by lifestyle factors and lack of preventive care. Bisphosphonates aid in the treatment of osteoporosis by decelerating the disintegration of bones, thereby improving bone strength and reducing fracture risk. For instance, Healthy Bones Australia, a bone health research and advocacy organisation based in Australia, reported in August 2024 that there were approximately 193,482 fractures caused by osteoporosis and osteopenia in 2023. This number is predicted to surge by 34% to 237,632 fractures by 2033. As a result, the growing cases of osteoporosis are fuelling the expansion of the bisphosphonates market. The surge in research activities and clinical trials is also anticipated to boost the bisphosphonates market’s growth. Clinical trials represent research studies involving human subjects to assess the safety, effectiveness, and potential side effects of novel medical treatments, drugs, or devices. The growing focus on research and clinical trials is largely due to the rising demand for novel treatments to cater to the ever-evolving healthcare needs and enhance patient outcomes. Clinical studies regarding bisphosphonates facilitate the progress of therapies for bone health by assessing their effectiveness, safety, and long-term impacts in preventing and addressing conditions like osteoporosis and bone metastases. For example, a study by the Association of the British Pharmaceutical Industry (ABPI), a UK-based association, in November 2023 reported a marginal 4.3% increase in the annual initiation of industry clinical trials in the UK, growing from 394 trials in 2021 to 411 in 2022. Consequently, the escalating emphasis on research and clinical trials is expected to further push the growth of the bisphosphonates market.

What Segmentation Categories Are Included In The Bisphosphonates Market Analysis?

The bisphosphonates market covered in this report is segmented –

1) By Type: Alendronate, Ibandronate, Risedronate, Zoledronic Acid

2) By Route Of Administration: Oral, Intravenous, Subcutaneous, Intraosseous, Intramuscular

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

4) By Application: Osteoporosis, Paget’s Disease, Bone Metastasis, Other Application

5) By End-User: Hospitals, Clinics, Homecare Settings, Pharmaceutical Retail

Subsegments:

1) By Alendronate: Oral Tablets, Once-Weekly Formulation, Combination With Vitamin D, Generic Alendronate

2) By Ibandronate: Oral Tablets, Monthly Oral Formulation, Intravenous Injection, Generic Ibandronate

3) By Risedronate: Immediate-Release Tablets, Delayed-Release Tablets, Weekly And Monthly Dosing, Combination With Calcium

4) By Zoledronic Acid: Intravenous Infusion, Annual Dosing, Oncology Use, Osteoporosis Use, Generic Zoledronic Acid

Who Are The Top-Ranked Companies In The Bisphosphonates Market Today?

Major companies operating in the bisphosphonates market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Organon & Co., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Alkem Laboratories, Natco Pharma Ltd., Strides Pharma Science Limited, Radius Health Inc., Warner Chilcott

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/bisphosphonates-global-market-report

How Is Bisphosphonates Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the bisphosphonates market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bisphosphonates market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24483&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model